Tian Xie

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 22

Top Topics

Candida Albicans

Respiratory Syncytial Virus

Top Venues

Expert opinion on therapeutic patents

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ruonan Zhang, Yintao Zheng, Qianru Zhu, Xiaoqing Gu, Bo Xiang, Xidong Gu, Tian Xie, Xinbing Sui
β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Ruonan Zhang, Yintao Zheng, Qianru Zhu, Xiaoqing Gu, Bo Xiang, Xidong Gu, Tian Xie, Xinbing Sui
β-Elemene Reverses Gefitinib Resistance in NSCLC Cells by Inhibiting lncRNA H19-Mediated Autophagy. Pharmaceuticals (Basel, Switzerland) 17 (5) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Bo-Wen Sun, Peng-Peng Zhang, Zong-Hao Wang, Xia Yao, Meng-Lan He, Rui-Ting Bai, Hao Che, Jing Lin, Tian Xie, Zi Hui, Xiang-Yang Ye, Li-Wei Wang
Prevention and Potential Treatment Strategies for Respiratory Syncytial Virus. Molecules (Basel, Switzerland) 29 (3) (2024)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents (2023)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents 32 (12) (2023)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents 32 (12) (2023)
Yuyang Liu, Shiyi Wu, Kaer Lan, Qian Wang, Tingyu Ye, Huanan Jin, Tianyuan Hu, Tian Xie, Qiuhui Wei, Xiaopu Yin
An Investigation of the JAZ Family and the CwMYC2-like Protein to Reveal Their Regulation Roles in the MeJA-Induced Biosynthesis of β-Elemene in Curcuma wenyujin . International journal of molecular sciences 24 (19) (2023)
Jinyun Dong, Jilong Duan, Zi Hui, Carmen Garrido, Zhangshuang Deng, Tian Xie, Xiang-Yang Ye
An updated patent review of protein arginine N-methyltransferase inhibitors (2019-2022). Expert opinion on therapeutic patents 32 (12) (2023)
E Wu, Jun-Tao Ni, Zhao-Hui Zhu, Hong-Quan Xu, Lin Tao, Tian Xie
Association of a Healthy Lifestyle with All-Cause, Cause-Specific Mortality and Incident Cancer among Individuals with Metabolic Syndrome: A Prospective Cohort Study in UK Biobank. International journal of environmental research and public health 19 (16) (2022)
Suwen Hu, Zi Hui, Jilong Duan, Carmen Garrido, Tian Xie, Xiang-Yang Ye
Discovery of small-molecule ATR inhibitors for potential cancer treatment: a patent review from 2014 to present. Expert opinion on therapeutic patents 32 (4) (2022)
Li-Wei Wang, Songwei Jiang, Ying-Hui Yuan, Jilong Duan, Nian-Dong Mao, Zi Hui, Renren Bai, Tian Xie, Xiang-Yang Ye
Recent Advances in Synergistic Antitumor Effects Exploited from the Inhibition of Ataxia Telangiectasia and RAD3-Related Protein Kinase (ATR). Molecules (Basel, Switzerland) 27 (8) (2022)
Cunjie Chang, Muthukumar Rajasekaran, Yiting Qiao, Heng Dong, Yu Wang, Hongping Xia, Amudha Deivasigamani, Minjie Wu, Karthik Sekar, Hengjun Gao, Mengqing Sun, Yuqin Niu, Qian Li, Lin Tao, Zhen Yan, Menglan Wang, Shasha Chen, Shujuan Zhao, Dajing Chen, Lina Li, Fan Yang, Haojin Gao, Baodong Chen, Ling Su, Liang Xu, Ye Chen, Veerabrahma Pratap Seshachalam, Gongxing Chen, Jayantha Gunaratne, Wanjin Hong, Junping Shi, Gongying Chen, David S Grierson, Benoit Chabot, Tian Xie, Kam Man Hui, Jianxiang Chen
The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma. Nature communications 13 (1) (2022)
Huijuan Cheng, Qian Yang, Rongrong Wang, Ruhua Luo, Shanshan Zhu, Minhui Li, Wenqi Li, Cheng Chen, Yuqing Zou, Zhihua Huang, Tian Xie, Shuling Wang, Honghua Zhang, Qingchang Tian
Emerging Advances of Detection Strategies for Tumor-Derived Exosomes. International journal of molecular sciences 23 (2) (2022)
Suwen Hu, Zi Hui, Frederic Lirussi, Carmen Garrido, Xiang-Yang Ye, Tian Xie
Small molecule DNA-PK inhibitors as potential cancer therapy: a patent review (2010-present). Expert opinion on therapeutic patents 31 (5) (2021)
Suwen Hu, Songwei Jiang, Xiang Qi, Renren Bai, Xiang-Yang Ye, Tian Xie
Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review. Drug development research (2021)
Tiantian Tan, Jie Li, Ruhua Luo, Rongrong Wang, Liyan Yin, Mengmeng Liu, Yi-Ying Zeng, Zhao-Wu Zeng, Tian Xie
Recent Advances in Understanding the Mechanisms of Elemene in Reversing Drug Resistance in Tumor Cells: A Review. Molecules (Basel, Switzerland) 26 (19) (2021)
Xingrui He, Xiao-Tao Zhuo, Yuan Gao, Renren Bai, Xiang-Yang Ye, Tian Xie
β-Elemene derivatives produced from SeO2-mediated oxidation reaction. Royal Society open science 7 (5) (2020)
Xingrui He, Xiabin Chen, Hancheng Zhang, Tian Xie, Xiang-Yang Ye
Selective Tyk2 inhibitors as potential therapeutic agents: a patent review (2015-2018). Expert opinion on therapeutic patents 29 (2) (2019)